Cleancore Solutions, Inc. (ZONE) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on June 5, 2025, and June 6, 2025, with the report filed on June 11, 2025. The filing details the resolution of two significant legal disputes and the results of the Company's Annual Meeting of Stockholders held on June 5, 2025.
Key Financial Metrics and Material Agreements
The filing does not provide standard financial metrics such as revenue, profit, cash flow, or debt levels. Instead, it discloses specific financial obligations arising from settlement agreements:
- Atkinson Settlement: The Company agreed to issue 200,000 shares of Class B Common Stock to the James T. Coyle Legacy Trust to resolve a lawsuit with former CEO Matthew Atkinson. The effective date is June 21, 2025.
- Boustead Settlement: The Company agreed to pay Boustead Securities, LLC $100,000 in cash within 45 days. An additional $1,050,000 is contingent upon the closing of a financing transaction of at least $50 million. If a smaller financing occurs, the Company must pay 2% of funds disbursed until the $1,050,000 threshold is met.
- Equity Issuance: On June 9, 2025, the Company issued warrants to Boustead for 29,750 shares at $1.25/share and 9,426 shares at $1.06/share. Additional "Transaction Warrants" for 160,824 shares are contingent on a future financing.
Material Changes and Corporate Actions
The primary material changes involve the termination of pending litigation and the issuance of unregistered securities:
- Litigation Resolution: The lawsuit filed by Matthew Atkinson in August 2024, alleging employment-related claims, will be dismissed with prejudice upon the settlement's effective date. Each party bears its own legal fees.
- Annual Meeting Results: Stockholders representing 68% of outstanding shares voted on three proposals:
- Director Election: Clayton Adams, David Enholm, Brent Cox, and Peter Frei were elected to the Board.
- Auditor Ratification: TAAD, LLP was ratified as the independent registered public accounting firm.
- Equity Plan Amendment: Stockholders approved Amendment No. 2 to the 2022 Equity Incentive Plan to increase the share reserve.
Outlook, Risks, and Contingencies
The Boustead Settlement Agreement introduces specific contingencies regarding future capital raising:
- Financing Deadline: If the Company fails to execute a term sheet for a financing transaction within six months or fails to close and pay compensation within one year, the settlement agreement expires, and obligations under the original Boustead Agreements may resume.
- Confidentiality: Both settlement agreements include standard confidentiality and non-disparagement provisions.
- Exemptions: The issuance of shares and warrants is being made in reliance on exemptions from registration requirements under Section 5 of the Securities Act of 1933.
Key Facts for Investor Verification
- Verify the dilution impact of the 200,000 shares issued to the Atkinson Trust and the potential issuance of up to 200,000+ warrants to Boustead Securities.
- Confirm the Company's ability to raise the $50 million financing required to trigger the full $1,050,000 payment to Boustead, or assess the cash flow impact of the 2% fee on smaller financings.
- Review the full text of the Settlement Agreements (Exhibits 10.1 and 10.2) for any omitted confidential terms that may affect future operations.
- Monitor the timeline for the dismissal of the Atkinson lawsuit, which is scheduled for five business days after June 21, 2025.